Industry
Medical - Devices
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
Loading...
Open
7.91
Mkt cap
198M
Volume
32K
High
8.22
P/E Ratio
-5.98
52-wk high
11.69
Low
7.67
Div yield
N/A
52-wk low
7.11
Portfolio Pulse from
November 10, 2024 | 2:00 pm
Portfolio Pulse from
November 08, 2024 | 12:45 am
Portfolio Pulse from
November 06, 2024 | 4:00 pm
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 9:55 pm
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 9:38 pm
Portfolio Pulse from Benzinga Newsdesk
July 16, 2024 | 1:18 pm
Portfolio Pulse from Avi Kapoor
July 16, 2024 | 12:05 pm
Portfolio Pulse from Benzinga Newsdesk
July 16, 2024 | 9:30 am
Portfolio Pulse from Benzinga Newsdesk
May 09, 2024 | 9:19 pm
Portfolio Pulse from Benzinga Newsdesk
May 09, 2024 | 8:50 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.